Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Dexamethasone + Levofloxacin
Ducressa
Not routinely available
SMC (SMC2511)
30/11/2022
Indication
Prevention and treatment of inflammation, and prevention of infection associated with cataract surgery in adults. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Therapeutic Area
Eye
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
levofloxacin 5mg/mL plus dexamethasone 1mg/mL eye drops solution
Comments
November 2022 - Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines.
Link to Advice
Advice Published
07/11/2022
SMC Submission Type
Abbreviated
SMC Status
Accepted